Piedmont HealthCare is dedicated to improving health care in our community and advancing the medical field through clinical research.
Clinical Research
WHAT
Clinical trials are designed to collect pivotal knowledge about investigational medications, the effectiveness of medical devices, the potential for new cancer screening options that may benefit future patients and current research participants. The trials are designed to assess both the safety and effectiveness of a product and are conducted under rigorous U.S. Food and Drug Administration (FDA) guidelines. Information or data during the study is reviewed to ensure its safety or effectiveness. That data is then submitted to the FDA, which reviews the data and approves or denies a new drug, device, or test to go to market.
WHY
- Improving healthcare outcomes for patients
- Reducing the cost of healthcare to patients and across the system
- Improving patient engagement and satisfaction with their healthcare experience
By participating, you may contribute to the healthcare of tomorrow and take a step towards improving and educating yourself about your own health. You may have a positive impact on the health of millions — perhaps even your own friends and loved ones. Research studies can allow you access to medical options and medications not available through any other means. Compensation may be offered.
HOW
Piedmont HealthCare patients are eligible to enroll in clinical trials in a few different ways
- Review our clinical trials to see if any apply to you and your medical situation. Fill out an interest form. Our team will outreach you to let you know if you qualify to enroll. Our goal is to match patients with clinical trials that are right for you.
- Your doctor may talk to you about clinical studies or recommend you for a specific trial.
- Our research department may reach out if they feel you are a good fit.
Once enrolled in a study, there will be specific criteria and instructions to complete the trial.
Our Partners
FAQs
Are clinical trials safe?
Yes. Before starting the trial, you will be given an informed consent form outlining the details of the research study. This form includes information on why the study is being conducted, how long it will last, procedures you may need to undergo, contact information, risks, and possible benefits. In addition, as stated above, all clinical studies follow rigorous FDA rules.
How many studies can I be part of?
You can take part in as many clinical studies as you qualify for, but you can only be part of one study at a time.
Does PHC partner with medical research companies?
Yes. Piedmont HealthCare works with two trusted research partners on many of the studies we offer: Accellacare and Innovo Research. Both are verified partners who collaborate closely with PHC physicians. If you are contacted by them, you can feel confident the outreach is part of our clinical research program.
What if I don’t qualify for a study?
If you don’t qualify for a specific study, that’s okay. There will be other studies for you to take part in.
Are there questions I should ask before I say yes to a clinical trial?
• Why is this trial being conducted?
• Should I tell my family doctor that I’m part of a study?
• Does the new medicine treat any other conditions?
• Is there a possibility I will receive a placebo?
• Can I take my current prescriptions during the study?
• How much does the study cost?
• What if I decide I don’t want to be part of the study?
• How do I tell my friends and family about clinical research?
Open Studies
*In partnership with Innovo*
Medical Condition: Chronic kidney disease with hypertension (Arctic and Pacific)
Facility: 340 Signal Hill Drive—Dr. Moran and Dr. Dwight Bellingham
Age: >18 years of age
Gender: M/F
Enrollment: Patient
Commitment Duration: Approximately 2 years
Number of Visits in Study: 11-13
Patient compensation will be available: You will be paid $150 per completed Screening Visit, $100-$200 for every other completed study visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Chronic Heart Failure (CHF)
Facility: 633 Brookdale Drive, Suite 100, Statesville—Dr. Rajper
Age: 18+
Gender: M/F
Enrollment: Patient
Commitment Duration: This is data driven and will last 1-5 years
Number of Visits in study: 11+
Patient compensation will be available: Enrollment and compensation pending
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Accellacare*
Medical Condition: Covid Vaccine
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Active
Commitment Duration: 1-year, weekly nasal swabs post vaccination
Number of Visits in study: 6 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Non-Cirrhotic Nonalcoholic Steatohepatitis(NASH)/Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Facility: 208 Old Mocksville
Age: 18-80
Gender: M/F
Enrollment: Active
Commitment Duration: 240 weeks: After enrollment visits are weekly for the first 4 weeks on treatment then monthly. After week 52 they are every 12 weeks
Number of Visits in study: 25 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity with Type II Diabetes
Facility: 208 Old Mocksville Rd
Age: 40-80
Gender: M/F
Enrollment: Active
Commitment Duration: 53 Weeks: 17 in office visits and 36 weekly in office dosing visits, 1 eye exam and 2 optional Full Body MRI
Number of Visits in study: Up to 53
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Chronic Obstructive Pulmonary Disease
Facility: 208 Old Mocksville Rd
Age: 40-80
Gender: M/F
Enrollment: Active
Commitment Duration: 3 years,3 visits within first month, then every 3 months for the first year and every 6 months until end of study.
Number of Visits in study: Up to 11 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Pediatric Migraines
Facility: 208 Old Mocksville Rd
Age: 6-12 years old
Gender: M/F
Enrollment: Starting Jun 2025
Commitment Duration: 28 days, 4 office visits, 2 phone call visits
Number of Visits in study: 6 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity or Overweight with Type II Diabetes
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Starting in August 2025
Commitment Duration: 34 weeks, 1 eye exam
Number of Visits in study: 16 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Patients with type 2 diabetes, hypertension and established cardiovascular disease
Age: >18
Gender: M/F
Enrollment: Starting in July 2025
Commitment Duration: 1.5 years
Number of Visits in study: 14 Visits: 9 Office visits and 5 phone call visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Facility: 208 Old Mocksville Rd
Age: >45
Gender: M/F
Enrollment: Starting in July 2025
Commitment Duration: 5 years, includes a 2-year open label extension
Number of Visits in study: 39 Office visits and every 4 weeks phone call visit
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity with Heart Failure
Facility: 138 Sherlock Dr.
Age: >18
Gender: M/F
Enrollment: May 2026
Commitment Duration: 84 weeks
Number of Visits in study: 23 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity with OA of the Knee
Facility: 138 Sherlock Dr.
Age: >18
Gender: M/F
Enrollment: May 2026
Commitment Duration: 156 weeks
Number of Visits in study: 23 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Heart Failure
Facility: 708 Hartness Rd. -Dr. Naveed Rajper
Age: >18
Gender: M/F
Enrollment Starting: Jun 2026
Commitment Duration: 20-35 months with an optional 2-year open label extension
Number of Visits in study: 60 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
Piedmont HealthCare is proud to partner with Accellacare & Innovo Research to conduct clinical studies.
To learn more about our partners, follow the links below.